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LSC: Limbal Stem Cell; LSCD: Limbal Stem Cell Deficiency; TAC: 
Transit Amplifying Cell; TDC: Terminally Differentiated Cell; CK: 
Cytokeratin; ABCG2: ATP-Binding Cassette Transporter G2; LEC: 
Limbal Epithelial Crypt; LC: Limbal Crypt; CX: Connexins; LEC: 
Limbal Epithelial Cell; ESC: Embryonic Stem Cell; HCjE: Conjunctival 
Epithelial Cell; BM-MSC: Bone Marrow-Derived Stem Cell; EpiASC: 
Epidermal Adult Stem Cell; IDPSC: Immature Dental Pulp Stem 
Cell; HFSC: Hair Follicle-derived Stem Cell; MSC: Mesenchymal 
Stem Cells; AM: Amniotic Membrane; CLAU: Conjunctival Limbal 
Autograft; KLAL: Keratolimbal Allograft; HPCLK: Homologous 
Penetrating Central Limbo-Keratoplasty; SLET: Simple Limbal 
Epithelial Transplantation; lr-CLAL: Living-related Conjunctival 
Limbal Allografts
Introduction 
The cornea is a transparent and avascular tissue, located at the 
front part of the eye. Its main function is to transmit and focus light 
to the correct position at the back of the eye for visual perception. 
Corneal tissue comprises three major layers: epithelium on the 
superficial surface, a stroma on the middle layer, and endothelium 
on the inner surface. The corneal epithelium sheds with stratified 
epithelial cells, and is thought to be replaced by stem cells located at 
the narrow edge of the cornea, in a region known as the limbus. The 
limbal region of the cornea provides a unique reservoir of corneal 
epithelial stem cells: limbal stem cells (LSC) are thought to be the 
main source for the regeneration of corneal epithelium following 
injury. A deficiency of limbal stem cells (LSCD) results in failure 
of corneal regeneration following injury, with consequent poor 
repair and ultimately loss of corneal transparency and subsequent 
blindness. In the past few decades, intensive research has focused on 
corneal stem cells as a source of regenerative cell-based therapy. This 
review summarizes the current knowledge of corneal epithelial stem 
cells and LSC-based transplantation in the regeneration of corneal 
epithelium. We will first review old and new information about the 
corneal structure. Second, we will discuss the current concept of 
LSCs; third, we will review studies of LSC-based transplantation and 
their advantages and disadvantages. Finally, we will discuss the future 
applications of LSCs.
Corneal Structure: Old and New Discoveries 
As the window of the eye, the healthy cornea remains completely 
transparent and plays a major role in visual information. The clear 
cornea covers the front of the eye and is surrounded by the outer 
conjunctiva and inner sclera. These enclosing structures maintain the 
eyeball’s globe shape and protect the internal functional content.
The crucial function of vision is achieved by the highly specialized 
corneal structure, previously described as comprising five layers: 
epithelium, Bowman’s layer, stroma, Descemet’s membrane and 
endothelium. Transparency of the cornea is essential for clear vision 
and is achieved by a smooth epithelium with no encroachment of 
conjunctival cells. The transparency of the cornea also is associated 
with the absence of vasculature, uniformly spaced collagen fibers, 
a functional endothelium that regulates corneal hydration and the 
production of crystalline proteins by keratocytes in the stroma [1,2]. 
The smooth epithelium is the uppermost part of the whole tissue, 
providing a non-keratinized, stratified squamous layer. Differentiated 
squamous cells present microvilli (finger-like projections) and 
microplicae, with a glycocalyx scaffold coating the surface. These 
components provide the structural framework to support and bind a 
complex of related factors, including tears, mucus, immunoglobulins 
and compact junctions between the epithelial cells, and constitute a 
protective barrier against invasion by infection [3]. During normal 
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Abstract
The clear cornea functions like a window that controls 
the entry of light for visual information and plays a protective 
role. The failure of appropriate repair following corneal injury 
results in loss of corneal function. The limbal region of the 
cornea is thought to serve as a unique reservoir of corneal 
epithelial stem cells where limbal stem cells (LSC) contributed 
to the regeneration of corneal epithelium. The deficiency 
of LSC (LSCD) results in the failed regeneration of corneal 
epithelium following injuries. In this review, we discuss the 
current knowledge of LSC and LSC-based transplantation 
for regeneration of corneal epithelium. We will first review 
the latest development of corneal structures. Next we will 
introduce the concept of LSC and the associated debates. 
Third, we will review different LSC-based transplantation 
methods for LSCD treatment and compare their advantages 
and disadvantages. Finally, we will discuss the improvements 
of regeneration of corneal epithelium.
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blinking, dead squamous cells are sloughed from the corneal 
epithelium. The corneal epithelium is subject to a constant cycle of 
cell renewal approximately every 9-12 months [4]. Epithelial cell loss 
from the corneal surface was defined in the “X, Y, Z hypothesis” by 
Thoft and Friend in 1983 [5]. The naturally desquamated epithelial 
cells (Z) are constantly replaced by proliferating and dividing cells 
at the basal epithelium (X), and cells which can migrate to the centre 
from the periphery (Y). 
X +Y = Z
Thus, migration occurs centripetally and circumferentially from 
the limbus and vertically from the basal layer forwards. Although 
the hypothesis is still questionable, there is a number of evidence to 
support this original observation. Remarkably, the animal study data 
supported the clinical results in LSCD patients [6-10].
The Bowman’s layer is acellular and composed of collagen fibrils, 
lying between the epithelium and stroma as a separate entity from 
the subepithelial basement membrane. This layer may be a visible 
indicator of ongoing stromal-epithelial interactions in the human. 
When stromal-epithelial interactions are disturbed in diseases, the 
Browman layer is commonly broken up [11]. The stroma, which 
constitutes up to 90% of the thickness of the cornea, is made up of 
bundles of regular spatial, near-uniformly thick connective collagen 
type I and IV fibers. The fibers are produced by keratocytes and 
embedded by an extracellular matrix. Stromal-epithelial interactions 
are bi-directional communications mediated by soluble cytokines 
during development, homeostasis, and wound healing in organs. 
The stromal-epithelial interactions in the cornea are regulated by 
hepatocyte growth factor (HGF) and keratinocyte growth factor 
(KGF). HGF and KGF are released by the keratocytes to modulate 
physiologic functions of epithelial cells, like proliferation, motility 
and differentiation. The epithelial to stromal interactions are also 
modulated by interleukin-1 (IL-1) and soluble Fas ligand, which are 
produced by corneal epithelial cells following injury. IL-1 dominantly 
regulates corneal wound healing through functions such as matrix 
metalloproteinase, HGF and KGF production, and apoptosis of 
keratocytes. The Fas/Fas ligand system primarily contributes to the 
immune privileged status of the cornea. Other cytokines, including 
epithelium growth factor from keratocytes and tumor necrosis factor 
α from epithelial cells, also play the important roles in the interactions 
[12]. Besides the corneal epithelial cells [13], and keratocytes in the 
supporting stroma [14], there are another two sources supplying 
multiple cytokines in the maintenance and healing of the cornea: the 
adjacent tear film [15], the aqueous humor [16].
The Descemet’s membrane, which can regenerate following 
injury, serves as the modified basement membrane between the 
stroma and the endothelium. The endothelium is the innermost, 
single hexagon-shape cell layer of the cornea. With a different origin, 
function and appearance to vascular endothelium, it governs the 
transport of nutrients and retains the slightly dehydrated state of the 
cornea [17]. Compared to some mammals such as rabbits, guinea 
pigs and cats, the human endothelium lacks a complete regenerative 
capacity through cellular division and subsequent migration, which is 
similar to the monkey’s endothelium [18].
Concept of Limbal Stem Cells and the Associated 
Debates
Limbus microenvironment
The limbus is the border zone between the transparent cornea and 
Conjunctiva
Limbus
Peripheral
  cornea
LSC (+) ABCG2, ∆Np63ά, N-Cadherin, CK14, CK15, C/EBPᵹ
(-) CK3, CK12, CX43
Differentiated corneal
epithelial cell
Conjunctival epithelial
cells
TACs and TDCs
Figure 1: The illustration of limbus and surrounding epithelium region. Limbal epithelium consists of more than 10 cell layers and is the thickest among the three 
as compared to 1-2 cell layers for the conjunctival epithelium and 4-6 cell layers for the corneal epithelium. The upper few epithelial layers are flat-shaped. Limbus 
basal cells express a combination of putative ‘LSC markers’.
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the opaque ‘whites of the eye’. Various studies related to the limbal 
microenvironment suggest that this special region participates in 
maintaining “stemness.” Histologically, limbal epithelium is unique; it 
consists of more than 10 cell layers and is the thickest among the three 
as compared to 1-2 cell layers for the conjunctival epithelium and 4-6 
cell layers for the corneal epithelium [19] (Figure 1). In humans, a 
regional specialization of the epithelial structure in the limbus was 
first speculated by Davanger and Evensen, and called ‘palisades 
of Vogt’ [20]. This structure is rich in melanin content, which can 
protect LSC from UV damage. The basal cells of this structure, some 
of which are the presumed LSC, are tightly attached to the underlying 
basement membrane and have a rich network of blood supply through 
the characterized radially oriented fibrovascular ridges. The ridges 
are more common in the superior and inferior quadrants around the 
eye. The palisades of Vogt are composed of stromal invaginations, 
allowing access to chemical signals that diffuse from the underlying 
vascular network [21]. In 1986, Schermer A et al. presented a 64K 
keratin, cytokeratin 3 (CK3), was positively expressed in the limbal 
basal layer, and led strong support of LSC location in the limbus [22]. 
In 1989, George Cotsarelis et al. identified a subpopulation of slow-
cycling limbal basal cells using 3H-thymidine labeling, which shared a 
set of common features with various epithelial stem cells. In common 
with other adult somatic cells, LSCs are small in size, have a high 
nuclear to cytoplasmic ratio, and lack expression of differentiation 
markers. In the event of injury, the slow cycling LSCs become highly 
proliferative [23]. These putative LSCs simultaneously retain their 
capacity for self-renewal and maintain a constant cell number by 
giving rise to fast-dividing progenitor cells, termed transit amplifying 
cells (TAC) [24]. These TAC compose the majority of the proliferative 
cell population in the corneal/limbal epithelium, and can experience 
a limited number of divisions before turning into terminally (post-
mitotic) differentiated cells (TDC) [22]. The process of TDC shedding 
from the ocular surface during normal wear and tear stimulates 
epithelial cell division, migration, and differentiation [1,25] (Figure 
2A and 2B). The differences between the two progenitor cells, LSC and 
TAC, are various, such as the expression of some markers (see 2.2), 
pigment protection, cell cycle length, response to tumor promoter 
[23,26,27] cell size, and ex vivo expansion supported material [28]. 
The limbal microenvironment termed “LSC niche” is first 
proposed by Schofield in 1983 [29]. The niche serves as a ‘reservoir’ for 
harboring and supporting a small population of putative LSCs, as well 
as providing a barrier to excessive growth of conjunctival cells and 
invasion of blood vessels into the cornea. The conjunctival ingrowth 
of the cornea occurs when the protective function fails and stable 
immunity of the cornea is destroyed. Environmental factors of niche 
include the limbal extracellular matrix, particularly the basement 
membrane, cell-matrix interactions, and cell-cell contacts. The 
underlying limbal stroma with keratocytes and blood supply network 
also plays a role in this environment by releasing various soluble 
cytokines [30-32]. In 1989, Kolega J et al. found that the basement 
membrane component AE-27 expressed weakly in the limbal region, 
and correlated with negative staining for CK3 [33]. In 1995, Ljubimov 
et al. gave rise to the assumption that the heterogeneity of the limbal 
LSC
LSC
LSC
TAC
TDC
conjunctiva
Limbus
Peripheral
corneal
Conjunctival
epithelial cells
Differentiated
corneal epithelial
cells
LSCs
TACs and TDCs
A
B
Figure 2: (A) A diagram denoting the self-renew and proliferative capability of limbal stem cells (LSCs). LSCs give rise to transit amplifying cells (TACs) as well as 
LSCs. TACs become mature and divide into terminally (post-mitotic) differentiated cells (TDCs). (B) A demonstration showing the relationship between LSC and 
other neighboring cells. LSCs locate in the basal layer of the limbal epithelium. LSC-derived TACs locate from the peripheral cornea to the central cornea, and 
gradually fail to proliferation. TDCs progressively replace the desquamated corneal differentiated epithelial cells.
Citation: Yan L, Jiang D, He J, Wong DSH, Lian Q. Limbal Stem Cells and Corneal Epithelial Regeneration: Current Status and Prospectives. J 
Ocular Biol. 2014;2(1): 10.
J Ocular Biol 2(1): 10 (2014) Page - 04
ISSN: 2334-2838
extracellular matrix might be partially responsible for the different 
cell phenotypes and proliferative behavior. The limbal basement 
membrane is composed of collagen IV (α1- 2) chains and laminin 
(α1-3, β1-3, γ1-2) chains; whereas collagen type IV (α3-5) chains 
and laminin (α1 and 3, β1 and 3, γ1-2) chains are contained in the 
corneal basement membrane [34-36]. Along this line, Espana et al. 
found that the CK3-negative phenotype of the limbal basal cells is 
mediated through the limbal stroma/basement membrane complex 
[37]. Diverse studies collectively point out that the niche is crucial 
in regulating the self-renewal and fate decision of LSC, although 
the precise mechanism remains obscure. In 2005, compared to 
submerged culture, the results of limbal explants air-lifting culture 
suggested that epithelial-mesenchymal transition via the Wnt/β-
catenin pathway influences the fate of limbal epithelial progenitor 
cells, between regeneration and fibrosis during wound healing when 
the stromal niche is activated [38]. 
Evidence of LSC
No single, definitive marker has yet been found to identify 
LSC despite numerous attempts. Nonetheless, the expression of a 
combination of ‘markers’ is used for identification and isolation of 
putative LSC, either positive (present) or negative (absent). Limbal 
basal cells lack differentiation markers such as CK3 that is present in 
all other layers of the corneal epithelium and the suprabasal layers of 
the limbal epithelium [22]. CK12 is also expressed in a similar pattern 
[39]. Involucrin is expressed in the corneal stratified squamous 
epithelium as a marker of differentiation [40]. Connexin 43 (CX43) 
is present in the corneal basal cells except that of the limbus for cell-
cell communication by gap junctions. The lack of CX43 expression 
in stem cells helps protect them against damage affecting adjacent 
neighbors [41].
Although the limbus is acknowledged as the site of corneal 
epithelial stem cells, the well-defined anatomical niche for LSCs was 
not described until 2005. Dua’s group re-evaluated the systematic 
serial 5-7 mm sections of human corneoscleral segments obtained 
from cadaver donors, with the corneal epithelial marker CK14 
and the “stem cell” marker ATP-binding cassette transporter G2 
(ABCG2) [42]. These distinct anatomical extensions from the limbal 
palisades, which consist of a solid cord of CK14/ABCG2-positive 
cells extending along the basal cells of the limbus more than along 
the basal cells of the adjacent conjunctiva, revealed features of being a 
LSC niche. This identified structure was termed the limbal epithelial 
crypt or limbal crypt [43]. Thus far, besides humans and pigs, a limbal 
epithelial crypt has not been discovered in other species [44]. 
Yang et al. first demonstrated that transcription factor p63 
was critical during epithelial development [45]. Initially, p63 was 
considered to be a specific LSC marker in human cornea [46]. 
However, later studies found that p63 was involved in normal 
development and carcinomas [47]. The preferential expression of 
∆Np63α (the α isoform of N-terminal transactivation domain-
negative p63) in activated human limbal basal layer suggested that 
∆Np63α was the most specific marker for LSC [48,49]. In 2007, using 
confocal imaging, Shortt et al. first provided the evidence in vivo that 
the structures of the palisades of Vogt are only one facet of the limbal 
niche architecture, forming the lateral walls of the stromal structures 
that encircle limbal crypts. Meanwhile, consistent with the previous 
studies [40,48], the putative LESC markers ABCG2 and ∆Np63α were 
expressed only by limbal basal cells and not by the corneal epithelium 
[50]. 
N-Cadherin and CK15 are two other promising candidate LSC 
antigens that co-localize to clusters of progenitor-like cells in the 
limbus [51]. The cell cycle arrest transcription factor C/EBPδ has also 
been implicated in the regulation of LSC self-renewal [52] (Figure 1).
The dogma that limbal stem cells are the exclusive source of 
corneal epithelial cells has been recently challenged. In 2008, Majo 
et al. found that in both mice and young children, healthy central 
corneal epithelium could generate holoclones with characteristics of 
stem cells that can maintain the corneal epithelium, probably without 
acute participation from the limbal region [53]. Furthermore, Dua et 
al. discovered normal central islands of corneal epithelium in adult 
eyes with clinically total limbal stem cell deficiency (LSCD) [54]. 
These data demonstrate that some LSCs remain and contribute to 
maintenance of the central epithelium in a clinically invisible way, or 
that basal cells of the central surviving epithelium can independently 
maintain the central epithelium. Nonetheless, the location of stem 
cells in the ocular surface may be species- or age-specific [54]. Majo 
et al. proposed the hypothesis that LSC functions response to injury 
and are not concerned with normal wear and tear of the corneal 
epithelium [53]. This remains to be determined by advanced studies 
related to the long-accepted TAC hypothesis. In addition, Dua et al. 
questioned whether LSC would regenerate the corneal epithelium 
in acute participation when the healthy central corneal islands were 
destroyed [54]. The first indication of the presence of LSCs was 
the observation in a rabbit that melanin moved centripetally from 
the limbus towards a corneal epithelial defect [55]. Limbal LSC 
transplantation following the corneal epithelium injuries in clinical 
practices indicated a high success rate of corneal wound healing, 
further supporting the hypothesis of the location of LSCs [20,56-59].
Limbal Stem Cell Deficiency and Treatment
Limbal stem cell deficiency
LSCD is characterized principally by damage or dysfunction of 
limbal stem cells with consequent invasion of conjunctival epithelium 
into the cornea [2]. The X or Y component of the X, Y, Z hypothesis 
is changed under such a pathologic condition, and induces failure of 
corneal homeostasis. 
The etiology of LSCD is varied but primarily includes congenital 
disease, ocular trauma or disease (e.g. trachoma, pterygium), 
autoimmune disease (e.g. Stevens Johnson syndrome and ocular 
cicatricial pemphygoid), systemic disease (e.g. diabetes), chemical 
burn, ultraviolet or ionising radiation, iatrogenic injury and contact 
lens-related pathology.
The process of conjunctivalization is considered the hallmark of 
LSCD [60]. The other combined clinical signs are also involved, such 
as goblet cell infiltration, corneal neovascularization, and persistent 
epithelial defects and scarring. As a consequence, LSCD culminates 
in visual impairment and persistent pain in patients [61]. LSCD is 
classified as partial or total, and unilateral or bilateral [62]. If the 
pupillary area is covered by encroaching conjunctival epithelium, 
intervening action should be undertaken [63], as well as the indication 
from significant ocular pain.
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Treatment of LSCD
A plentiful range of strategies to treat LSCD has been developed 
since 1940, when amniotic membrane (AM) was used in the first 
tissue-based procedure. Penetrating keratoplasty as the standard 
therapy of central corneal replacement is not available for LSCD, 
since restoration of the stem cell population is not involved [64], with 
the donor source and graft rejection as important limitations [19,65].
Current therapy of LSCD can be categorized using either cultured 
or non-cultured tissue or cell type for transplantation or alternative 
approaches without transplantation. In present review, we focus 
on the development of both cultured and non-cultured cell-based 
transplantation (Figure 3A and 3B).
In the first instance, conditions such as tear film deficiency, 
inflammation, lid abnormalities and corneal and conjunctival 
anesthesia should be investigated and addressed prior to surgery 
[66]. Use of cultured or non-cultured tissue and cell type should 
then be determined. Technically, the ideal method requires an easily 
accessible transplantation material, effective transplantation and 
stable clinical outcomes.
Cultured cell-based transplantation: In cultured LEC 
transplantation, LECs are expanded on substrate ex vivo from 
living or cadaver human cornea [67], and transplanted with or 
without the substrate onto the bare cornea that has been exposed by 
surgically removing the fibrovascular pannus (Table 1). Repeating 
this transplantation in the same eye can lead to higher final clinical 
success rate [68] and improvement in visual acuity [69]. The overall 
significant improvement rate of cultured LSC transplantation 
(according to the differently considerable criteria in different studies) 
was higher for autografts than for allografts [60,70,71]. The most 
common complications following transplantation included bleeding, 
inflammation, blepharitis and epitheliopathy. Less common 
was keratitis, residual fibrin, rejection of cultured LECs, corneal 
perforation, glaucoma, and infection [60,68,71-74]. Follow-up should 
continue for at least two years, especially since many complications are 
observed during the first year [68,69]. A benefit of this transplantation 
is that the risk of stem cell failure in the donor eye can be minimized 
via a small biopsy [75], with further opportunities to harvest LSCs 
[69,72]. Another advantage is the reduced risk of rejection of 
allografts compared with direct limbal tissue transplantation [76]. 
The major limitation is the high cost of stem cell procedures and high 
requirement of expertise. It remains unknown how cultured LSCs 
reconstruct the ocular surface. It is widely held that LECs may replace 
progenitor/stem cells, and/or revitalize dormant stem cells of the 
recipient by providing growth factors/chemotactic stimuli. 
Much attention has recently focused on oral mucosal epithelial 
cells [72,77,78] in contrast to other cultured non-LSC cell sources. 
The neovascularization that occurs following oral cell transplantation 
may be diminished by anti-angiogenic therapy [79]. As another 
feasible cell source, conjunctival epithelial cells, have been applied in 
animal and human LSCD models in the same way as oral cells [80,81]. 
Other documented cultured cell types include embryonic stem cells, 
A. Cultured cell-based transplantion
  LSC
source
Ex vivo system
    Graft for
transplantion
Substrate
Substrate
OR
B. Non-cultured cell-based transplantation
Donor eye
LSC tissue
     graft
LSCD host eye
Transplantation
(From alkali-induced
LSCD mouse model)
(From alkali-induced
LSCD mouse model)
(From normal mouse)
LSCD host eye
Figure 3: (A) The experimental process of cultured cell-based transplantation in LSCD treatment. LSCs in different cell types are expanded in various ex vivo 
system with substrate, and harvested cells with or without substrate are transplanted onto the ocular surface of hosts. The mouse model represents ocular 
appearance with LSCD caused by alkali burn. Some characteristic features of LSCD, e.g. vision reduction, neovascularization, and persistent corneal epithelial 
defect can be observed. (B) The experimental process of non-cultured cell-based transplantation in LSCD treatment. LSC-tissue grafts from different sites of donor 
ocular surface are directly transplanted onto the ocular surface of hosts. The mouse model represents both normal cornea and ocular appearance with LSCD 
caused by alkali burn. 
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Year
(1st publication)
Cell/Tissue
Type
Species Method of Transplantation (host) Outcomes Ref
1997 Limbal 
epithelial 
cells (LEC)
H Donor:
Autologous corneal epithelial sheets generated by serial 
cultivation of limbal cells cultivated from a 1 mm2 biopsy 
sample taken from the patient’s healthy eye, with complete 
loss of the corneal-limbal surface in the injured eye. 
Recipient: 
Human damaged eye.
Follow-up for more than 2 years showed 
the stability of regenerated corneal 
epithelium and the striking improvement in 
patients' comfort and visual acuity.
[82]
2003 Oral mucosal 
epithelial cells
R Donor:
Autologous oral mucosal biopsy specimens were 
cultivated for 3 weeks on a denuded AM carrier.
Recipient:
Rabbit conjunctivalized corneal surfaces at 3 to 4 weeks 
after total created corneal injury.
The cultivated oral epithelial sheets were 
very similar to normal corneal epithelium.
Grafted corneas were clear and were all 
epithelialized 10 days after surgery.
[83]
2004 Embryonic 
stem
 cells (ESC)
M Donor:
Epithelial progenitor cells derived from cultured mouse 
ESCs under optimal conditions.
Recipient:
Mouse corneas damaged by exposure to n-heptanol.
Cultured mouse ESCs induced epithelial 
progenitors induced successfully, 
with specific markers for corneal 
epithelial wound healing. Complete re-
epithelialization of the corneal surface 
occurred within 24 hours of transplantation 
without any teratoma observed.
[84]
2006 Conjunctival 
epithelial cells 
(HCjE)
R Donor:
HCjE cultivated on human AM to confluence and exposed 
to an air-liquid interface (air-lifted).
Recipient:
Rabbit corneas with total created injury.
The transplanted HCjE remained 
transparent, smooth, and without epithelial 
defects during the 2 weeks follow-up. The 
cultured cell sheets were similar in both 
morphology and molecular biology to 
normal corneal epithelium.
[85]
2006 Bone marrow-
derived stem 
cells
(BM-MSC)
Ra Donor:
BM-MSCs from healthy donors were grown and expanded 
on AM.
Recipient:
Rat corneas with chemical burns after 7 days.
The data showed that BM-MSCs 
successfully reconstructed damaged 
corneal surface. The inhibition of 
inflammation and angiogenesis after 
transplantation of BM-MSCs was more 
related to the therapeutic effect than the 
epithelial differentiation from BM-MSCs.
[86]
2007 Epidermal 
adult stem cells 
(EpiASC)
G Donor:
Cultivated goat EpiASC on denuded human AM.
Recipient:
Goats with total created LSCD.
The results showed repair of the damaged 
cornea.
[87]
2009 Immature 
dental 
pulp stem cells 
(IDPSC)
R Donor:
Cultured human IDPSC 
Recipient:
Rabbit corneas with total created LSCD after 30 days, 
accepted superficial keratectomy to remove the opaque 
tissue, and then got the transplantation. 
The data suggested that hIDPSCs share 
similar characteristics to LSC and can 
reconstruct the eye surface.
[88]
2010 Hair follicle-
derived stem 
cells
(HFSC)
M Donor:
Cultured mouse HFSCs on a fibrin carrier 
Recipient:
Mouse corneas with created LSCD.
It was able to reconstruct the ocular surface 
in 80% of the transplanted animals.
[89]
2011 Umbilical cord 
stem cells
R Donor:
Cultured human umbilical cord stem cells on a human AM.
Recipient:
Rabbit corneas with created LSCD.
Regeneration of a smooth, clear corneal 
surface with phenotypic expression of the 
normal corneal-specific epithelial markers.
[90]
2013 Orbital 
fatderived
stem cells 
(OFSC)
H Donor:
Cultured OFSCs from healthy donors were resuspended 
in PBS.
Recipient:
Rat corneas with 70 or 100% chemical burns.
Topical administration of OFSCs promoted 
corneal re-epithelialization of both the 
limbal-sparing and limbal-involved corneal 
wounds, which is superior to that of the 
Intralimbal injections.
[91]
Table 1: The list of the 1st publication using certain cell/tissue source related to cultured transplantation studies.
*H: Human; R: Rabbit; Ra: Rat; G: Goat; M: Mice
bone marrow-derived mesenchymal stem cells (MSCs), epidermal 
epithelial cells, human immature dental pulp stem cells, hair follicle-
derived stem cells, umbilical cord stem cells.
Non-cultured cell-based transplantation: A direct 
transplantation without requirements of cell culture procedures has 
been employed in various tissues (Table 2). Amniotic membrane 
(AM), the innermost layer of the placenta, serves broadly as an 
extracellular matrix for cell cultivation and a carrier for cultured cell 
transplantation. AM comprises a single layer of epithelium, a thick 
basement membrane and an avascular stroma and has been shown 
to support adhesion, migration, differentiation and proliferation of 
epithelial cells [97]. The dominant properties of AM substrate are 
low or no immunogenicity with anti-inflammatory, anti-angiogenic, 
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Year (1st publication) Tissue Type Species Method of Transplantation (host) Outcomes Ref
1940 Amniotic membrane (AM) Human (H) N/A N/A [92]
1989 Conjunctival limbal autograft(CLAU) H
Donor:
Two free grafts of limbal tissue from the 
uninjured or less injured donor eye.
 Recipient: 
Severely injured eye, which having been 
prepared by limited conjunctival research 
and superficial dissection of fibrovascular 
pannus without keratectomy.
After not less than 6 months, the data 
showed stable ocular surface with 
improved visual acuity and epithelial 
recovery, which may be better for 
lamellar or penetrating keratoplasty 
later. 
No complications for donors.
[93]
1990 Keratolimbal allograft(KLAL) H
Donor:
Corneal limbal epithelial cells.
Recipient:
Keratoepithelioplasty using allografts from 
donors.
For chronic ocular surface failure, it 
can help to establish a stable and 
clear optical surface after more than 4 
months.
[94]
1999
Homologous penetrating 
central limbo-keratoplasty
(HPCLK)
H
Donor: 
The eccentrically trephined unmatched 
grafts contained 40% limbus.
Recipient: 
A surgical one-stage procedure was done 
in the central of the corneas. Systemic 
cyclosporin A (CSA) was administered for at 
least one year. 
Central clear graft survival was the main 
outcome criterion.
The failed grafts were mostly because 
of postoperative immunerejection. The 
left grafts had remained centrally clear 
for 12–41 months.
[95]
2012
Simple limbal epithelial
transplantation
(SLET)
H
Donor:
A 2×2 mm strip of limbal tissue from the 
healthy eye was divided into 8-10 small 
pieces.
Recipient:
Patients with unilateral and total limbal stem 
cell deficiency following ocular surface burns 
underwent a single-stage procedure, with 
the tiny donor’s limbal evenly over an AM on 
thecorneas.
It showed a completely epithelialised, 
avascular and stable corneal surface 
after 6 weeks, lasted for around 9 
months. Visual acuity improved with no 
complications of donor eyes. 
[96]
Table 2: The list of the 1st publication using certain tissue source related to non-cultured transplantation studies.
and anti-scarring properties [98,99]. AM transplantation alone 
is not appropriate for total LSCD, but is feasible in partial LSCD 
therapy [100]. Recent studies have nonetheless indicated far broader 
applications of AM transplantation. For example, AM extract and 
non-cultured tissue combined with AM transplantation therapy 
[101,102].
Conjunctival limbal autograft (CLAU) [103] has limitations 
to be used for unilateral LSCD because limbal tissue attached to a 
conjunctival carrier from the healthy eye of the patient is required, 
and the transplantation process may increase the risk of LSCD in the 
healthy donor eye. In living-related conjunctival limbal allografts (lr-
CLAL), the grafts from a living relative of the patient show a poorer 
long-term outcome than CLAU due to the unavoidable need for 
systemic immunosuppression [103-105]. Living donor allografts are 
nonetheless superior to cadaver allografts.
Based on the different choices of allografts, homologous 
penetrating central limbo-keratoplasty (HPCLK) is associated with 
a greater risk of immune rejection than conventional penetrating 
keratoplasty [106], while keratolimbal allograft (KLAL) involves the 
transplantation of cadaveric limbal tissue with its abundance of stem 
cells, together with a small rim of corneal and scleral tissue [103,104]. 
A combination of AM or lr-CLAL and KLAL is performed in some 
cases [107].
Simple limbal epithelial transplantation (SLET) has been shown 
to be valuable in the management of human LSCD. Compared with 
cultured LEC transplantation, this process can notably reduce the cost 
and period of cell culture, using very small amounts of biopsy tissue. 
Further clinical data are essential for the improvement of SLET, and a 
novel biodegradable alternative to AM is required.
Challenges and Future Perspectives
Before corneal stem cell transplantation can be widely applied 
in clinical practice, a number of challenges need to be addressed. At 
present, most investigational protocols in corneal bioengineering 
and corneal stem cell therapy rely on the use of animal products and/
or allogeneic human cells and tissue. Such products raise potential 
risks, such as graft-versus-host disease, cataract, dry eye, glaucoma 
as well as animal transmitted diseases. More suitable material is 
urgently needed. A novel method of culturing expanded human 
limbal epithelial cells on human AM ex vivo has been developed using 
a cultured medium with autologous human serum as single growth 
supplement. Compared to the commonly used complex medium 
including FBS and other non-human derived products, omission 
of xenogenic ingredients may reduce the host immunogenicity of 
the transplanted tissue and also safeguard against the inter-species 
transmission [108]. Sequentially, above protocol was applied in 
clinical trial, and five in nine transplanted patients had obviously 
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achieved clinical improvement in 11 to 28 months follow-up [109]. 
From another point of view, the enzyme-related (e.g., trypsin-EDTA 
and dispase) dissociation or sequential incubation steps in cultured 
cell-based transplantation would induce DNA damage in the cell 
population destined for graft production. It is essential to maintain 
integrity of cellular and DNA repair mechanisms for proper cellular 
functioning including for long-term viability and proliferative 
potential. Therefore, it requires further optimization to improve ex 
vivo manipulating procedures and protocols to guarantee the quality 
of cell transplantation [110].
It is also important to systematically assess the advantages and 
disadvantages of cultured versus non-cultured limbal stem cell-
based transplantation. It requires more understanding of molecular 
signals that constitute the limbal stem cell niche. Simultaneously, 
considering that the reported success rate differs widely between 
studies and depends on various parameters including the sources of 
tissue and the indications for surgery/concomitant ocular pathology, 
it is warranted for well-defined and stringent criteria to further 
illuminate and evaluate the transplantation methods and therapeutic 
outcomes among the prospective studies. Preferably, a greater 
number of patients with long enough follow-up data are necessary 
to assess the efficiency and superiority of the cell types and technique 
in LSCD therapy [109]. In addition, there is no consensus on the 
specific markers to identify limbal stem cells making between-study 
comparisons difficult.
In summary, although it is urgently needed to acquire more 
knowledge on appropriate potential cell sources, scaffold material, 
and growth elements, the progress in both basic research and clinical 
treatments indicate that there is great hope for stem cell-based 
therapies for regeneration of corneal epithelium in the near future.
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